Rightway, an alternative pharmacy benefit manager (PBM), is trending upward and best positioned to challenge the "Big 3" ...

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

Cuppa Corner café at the Worthing Home has reopened for veterans and visitors after a six-year closure, supported by Caremark Worthing and Adur.

Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...

CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

Meta CEO Mark Zuckerberg and board have settled an $8 billion shareholder lawsuit over Facebook's user privacy violations, ...

Society / Forget Kennedy’s faux-populist, anti-science approach. The former FTC chair provides the real model of an ideal HHS ...

Meta shareholders abruptly settled an $8 billion lawsuit accusing Mark Zuckerberg and other executives of oversight failures ...

Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...

The FDA announced on Thursday that Juul can keep its products on the market, after the company submitted studies that claim ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...